Glenmark has launched Adapalene Gel USP, 0.1% (OTC) in new pump packs, which can be compared to the active ingredient of Differin Gel, 0.1%.

According to Nielsen syndicated data for the latest 52-week period ending September 5, 2026, the Differin Gel, 0.1% (OTC) market achieved annual sales of approximately USD 45.8 million.

Commenting on the launch, Marc Kikuchi, President and Business Head, North America, said, “The introduction of Adapalene Gel USP, 0.1% (OTC) in a new pump pack enhances consumer experience by offering a convenient and easy to use dispensing option while further strengthening our growing US dermatology portfolio. This launch reflects our commitment to delivering high quality and affordable health care solutions that meet evolving consumer needs.”